comparemela.com
Home
Live Updates
Hyloris announces submission of Maxigesic® IV packaging
Hyloris announces submission of Maxigesic® IV packaging
Hyloris announces submission of Maxigesic® IV packaging data requested by the US FDA
Additional extractable & leachable data generated by an accredited lab facility located in North AmericaResults analyzed and evaluated by toxicological expertsPotential regulatory approval for... | April 18, 2023
Related Keywords
United States ,
Belgium ,
America ,
American ,
Stijn Van Rompay ,
Sven Watthy ,
Jean Luc Vandebroek ,
Hyloris Pharmaceuticals ,
Investor Relations Communications ,
Hikma Pharmaceuticals ,
Hyloris Pharmaceuticals Sa Euronext Brussels ,
Linkedin ,
Food Drug Administration ,
Euronext Brussels ,
Drug Administration ,
Complete Response Letter ,
Van Rompay ,
Chief Executive Officer ,
Luc Vandebroek ,
Investor Relations ,
Persistent Opioid Use After Minor ,
Major Surgical Procedures ,
Hyloris Pharmaceuticals Sa Stock Exchange ,
News ,
Information ,
Press Release ,
Dditional ,
Xtractable ,
Teachable ,
Data ,
Enerated ,
Y ,
N ,
Aaccredited ,
Lab ,
Facility ,
Ocated ,
North ,
Mericaresults ,
Aanalyzed ,
End ,
Revaluated ,
Toxicological ,
Xpertspotential ,
Egulatory ,
Pproval Hyl Be0974363955 ,